newsfilter
← Latest News
PR Newswire·

BrainStorm Cell Therapeutics to Announce Second Quarter Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced ...